Appili Therapeutics' Grant - IV Round

Appili Therapeutics raised a round of funding on November 07, 2017. Investors include U.S. Department of Defense.

Appili is dedicated to identifying, acquiring and advancing therapeutics for infectious disease. The company has two anti-infective programs, ATI-1501 and ATI-1503, in its pipeline. ATI-1501 is a tast…

Articles about Appili Therapeutics' Grant - IV Round: